[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353178-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-353178-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","when-breast-cancer-meets-the-uterus-a-quantitative-review-of-105-cases-spanning-four-decades","When Breast Cancer Meets the Uterus - A Quantitative Review of 105 Cases Spanning Four Decades","","Uterine metastasis from breast carcinoma is rare, yet it creates substantial diagnostic and treatment challenges. A structured search of PubMed/MEDLINE and Google Scholar (1980–2025) identified 105 histologically confirmed cases with uterine involvement, followed by pooled analysis of demographic, histological, molecular, and clinical variables. Invasive lobular carcinoma predominated (58.0%) and tamoxifen exposure correlated with polyp-substrate metastasis. Abnormal uterine bleeding was most common; median latency was 36 months.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/when-breast-cancer-meets-the-uterus-a-quantitative-review-of-105-cases-spanning-four-decades/353178/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/when-breast-cancer-meets-the-uterus-a-quantitative-review-of-105-cases-spanning-four-decades/353178.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"How were the 105 cases identified and analyzed in the review?","Question",{"text":63,"@type":64},"The review used a structured search of PubMed/MEDLINE and Google Scholar (1980–2025) for cases with histologically confirmed breast primary and uterine involvement, followed by pooled analysis of demographic, histological, molecular, and clinical variables.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which breast cancer subtype and uterine locations were most frequently involved?",{"text":68,"@type":64},"Invasive lobular carcinoma accounted for 58.0% of classified cases. Uterine involvement included endometrial (68.6%), myometrial (25.7%), and cervical (26.7%) involvement.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does tamoxifen exposure play in uterine metastasis patterns?",{"text":72,"@type":64},"Tamoxifen exposure was strongly associated with polyp-substrate metastasis (29.3% vs. 4.7%, Fisher’s exact p = 0.0009; OR 8.41).",{"name":74,"@type":61,"acceptedAnswer":75},"What diagnostic approach does the review recommend for distinguishing metastatic disease from primary uterine pathology?",{"text":76,"@type":64},"It recommends using a combined immunohistochemical panel (GATA3, TRPS1, E-cadherin, hormone receptors, PAX8) to distinguish metastasis from primary uterine pathology.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},353178,1790319280,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":33,"preview_urls":151},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nWhen Breast Cancer Meets the Uterus: A Quantitative Review of 105 Cases Spanning Four Decades  \nTiberiu Augustin Georgescu 1,2, Antonia Carmen Georgescu 1,3, * and Maria Victoria Olinca 1  \nAcademic Editor: Simone Ferrero  \nReceived: 12 May 2026  \nRevised: 11 June 2026  \nAccepted: 18 June 2026  \nPublished: 22 June 2026  \nCopyright: © 2026 by the authors. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Discipline of Pathology,“Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania; [tiberiu.georgescu@umfcd.ro](tiberiu.georgescu@umfcd.ro) (T.A.G.); [maria.olinca@umfcd.ro](maria.olinca@umfcd.ro) (M.V.O.)  \n2 Department of Pathology, National Institute for Mother and Child Health “Alessandrescu-Rusescu”,  \n020395 Bucharest, Romania  \n3 Department of Pathology,“Carol Davila” Nephrology Hospital, 010731 Bucharest, Romania  \n* Correspondence: [antonia.georgescu@umfcd.ro](antonia.georgescu@umfcd.ro)  \nAbstract  \nBackground and Objectives: Uterine metastasis from breast carcinoma is rare but poses substantial diagnostic and therapeutic challenges. Invasive lobular carcinoma (ILC) demonstrates a documented predilection for unusual metastatic patterns including the female genital tract, while tamoxifen-associated endometrial pathology may complicate diagnosis in breast cancer survivors. Materials and Methods: We performed a structured PubMed/MEDLINE and Google Scholar search (1980–2025) for cases with histologically confirmed breast primary and uterine involvement; a pooled analysis of demographic, histological, molecular, and clinical variables was performed. Results: 105 individual cases were identified. ILC accounted for 58.0% of histologically classified cases despite representing only 10–15% of breast cancers. Endometrial involvement was present in 68.6%, myometrial in 25.7%, and cervical in 26.7% . Tamoxifen exposure was strongly associated with polyp-substrate metastasis (29.3% vs. 4.7%; Fisher’s exact p = 0.0009; OR 8.41, 95% CI 2.20–32.14) . Abnormal uterine bleeding was the dominant presentation (68.1%); 19.8% were asymptomatic. Median latency was 36 months (range from 24 months before to 360 months after the breast cancer diagnosis) . Conclusions: Uterine metastasis from breast carcinoma is dominated by invasive lobular histology and frequently involves tamoxifen-associated polyps. A combined immunohistochemical panel (GATA3, TRPS1, E-cadherin, hormone receptors, PAX8) is essential for distinguishing metastatic disease from primary uterine pathology. Endometrial sampling should be considered with a low threshold in breast cancer survivors with abnormal uterine bleeding, and breast imaging is warranted when discohesive cells are encountered without a known breast primary. These proportions describe the published case literature rather than population-based prevalence; because the evidence is limited to case reports and small series, they should not be read as the true frequency of uterine involvement among women with breast cancer.  \nKeywords: breast carcinoma; uterine neoplasms; invasive lobular carcinoma; endometrial metastasis; endometrial polyp; tamoxifen; immunohistochemistry; GATA3; TRPS1; E-cadherin  \n1. Introduction  \nBreast carcinoma is the most common malignancy in women globally and the leading cause of cancer-related death among women in many parts of the world. The natural history of metastatic spread is most often dominated by haematogenous dissemination to  \nthe bones, lungs, liver, and brain, with these four sites accounting for the great majority of distant metastases. Metastasis to the female genital tract from extragenital primaries is comparatively unusual, and when it does occur, the ovaries are the dominant site of involvement, followed by the vagina. The uterus is an uncommon","cbCaillMMHLhw7Fm","https://ap.wps.com/l/cbCaillMMHLhw7Fm","pdf",3801513,27,"English","# Abstract\n# 1. Introduction","[{\"question\":\"How were the 105 cases identified and analyzed in the review?\",\"answer\":\"The review used a structured search of PubMed/MEDLINE and Google Scholar (1980–2025) for cases with histologically confirmed breast primary and uterine involvement, followed by pooled analysis of demographic, histological, molecular, and clinical variables.\"},{\"question\":\"Which breast cancer subtype and uterine locations were most frequently involved?\",\"answer\":\"Invasive lobular carcinoma accounted for 58.0% of classified cases. Uterine involvement included endometrial (68.6%), myometrial (25.7%), and cervical (26.7%) involvement.\"},{\"question\":\"What role does tamoxifen exposure play in uterine metastasis patterns?\",\"answer\":\"Tamoxifen exposure was strongly associated with polyp-substrate metastasis (29.3% vs. 4.7%, Fisher’s exact p = 0.0009; OR 8.41).\"},{\"question\":\"What diagnostic approach does the review recommend for distinguishing metastatic disease from primary uterine pathology?\",\"answer\":\"It recommends using a combined immunohistochemical panel (GATA3, TRPS1, E-cadherin, hormone receptors, PAX8) to distinguish metastasis from primary uterine pathology.\"}]","When Breast Cancer Meets the Uterus - A Quantitative Review of 105 Cases Spanning Four Decades | PDF",1790103467,68,[152,156,160,164],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/588c005b775f68567b3458cd98fc0f23.webp",983,1390,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7459d1de3c7718154320585bfedf6f97.webp",982,1388,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32269d965ec18c1c2d54257fa821d313.webp",981,1387,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fb8337c2d0ae13891baca45294d23ef.webp",980,1385]